U.S. pharma huge copyright scrapped two experimental weight loss products final yr—a at the time-everyday capsule, lotiglipron, as a result of elevated liver enzymes and a two times-day by day capsule, danuglipron, because of powerful Unwanted side effects—but CEO Albert Bourla has m